Background

axSpA
AXIAL SPONDYLOARTHRITIS, CHRONIC INFLAMMATORY DISEASE
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease of the axial skeleton predominantly affecting the spine and sacroiliac (SI) joints [Secukinumab, a human monoclonal immunoglobulin (IgG1) antibody that selectively neutralizes human interleukin (IL)-17A, demonstrated rapid and sustained improvement in the signs and symptoms of AS in long-term treatment (up to 5 years) in the phase 3 MEASURE studies [